Clinical Trial 46648

Pearland, TX 77584


The purpose of this study is to look into the safety and efficacy of atogepant in the prevention of migraine

 - At least a 1-year history of migraine

 - History of 4 to 14 migraine days (see Section 8.1.1 for definition) per month on average in past 3 months

- a. Failed oral migraine medications from 2 to 4 of the medication classes as listed below:
i. Propranolol, metoprolol, atenolol, bisoprolol, timolol, or nadolol;
ii. Topiramate;
iii. Flunarizine;
iv. Valproate or divalproex;
v. Amitriptyline or nortriptyline;
vi. Venlafaxine or desvenlafaxine;
vii. Lisinopril;
viii. Candesartan;
ix. Locally approved products (eg, oxeterone or pizotifen)

b. Failed at least one treatment from the list below:
i. Propranolol OR metoprolol;
ii. Topiramate;
iii. Flunarizine;
iv. Amitriptyline

Qualified Participants May Receive:

You may be paid for your time and inconvenience. You will get $75.00 per visit for each study visit completed. You will be paid at the end of each study visit, in the study. If you do not finish the study, you will only be paid for the visits completed.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.